BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $259,064 | +2.5% | 6,701 | +0.0% | 0.06% | -4.8% |
| Q3 2023 | $252,850 | -21.2% | 6,699 | -4.9% | 0.06% | -18.4% |
| Q2 2023 | $320,821 | +12.3% | 7,041 | +0.0% | 0.08% | +10.1% |
| Q1 2023 | $285,565 | -4.7% | 7,040 | +20.0% | 0.07% | -6.8% |
| Q4 2022 | $299,587 | -99.9% | 5,869 | +0.0% | 0.07% | -12.9% |
| Q3 2022 | $316,095,000 | -16.1% | 5,868 | +0.1% | 0.08% | -11.5% |
| Q2 2022 | $376,715,000 | -10.7% | 5,865 | +7.8% | 0.10% | -2.0% |
| Q1 2022 | $421,779,000 | -11.6% | 5,439 | -2.1% | 0.10% | -8.4% |
| Q4 2021 | $477,012,000 | -19.4% | 5,556 | -19.2% | 0.11% | -46.8% |
| Q3 2021 | $591,854,000 | +33.4% | 6,874 | +24.7% | 0.20% | +84.4% |
| Q2 2021 | $443,788,000 | -4.5% | 5,512 | 0.0% | 0.11% | -10.7% |
| Q1 2021 | $464,919,000 | -15.5% | 5,512 | -19.6% | 0.12% | -22.3% |
| Q4 2020 | $550,202,000 | -1.4% | 6,856 | -0.2% | 0.16% | -29.9% |
| Q3 2020 | $558,066,000 | -5.7% | 6,873 | -0.0% | 0.22% | +11.4% |
| Q2 2020 | $591,854,000 | +6.1% | 6,874 | +0.0% | 0.20% | -10.3% |
| Q1 2020 | $558,066,000 | -4.0% | 6,873 | -1.2% | 0.22% | +23.8% |
| Q4 2019 | $581,592,000 | -4.8% | 6,955 | +0.0% | 0.18% | -12.6% |
| Q3 2019 | $611,118,000 | +1.5% | 6,954 | -5.8% | 0.21% | -1.0% |
| Q2 2019 | $602,005,000 | +0.3% | 7,379 | 0.0% | 0.21% | -2.8% |
| Q1 2019 | $599,986,000 | +23.5% | 7,379 | 0.0% | 0.22% | +9.1% |
| Q4 2018 | $485,685,000 | -11.6% | 7,379 | +3.5% | 0.20% | -1.0% |
| Q3 2018 | $549,574,000 | +4.6% | 7,129 | 0.0% | 0.20% | -2.9% |
| Q2 2018 | $525,610,000 | +12.4% | 7,129 | 0.0% | 0.20% | +10.8% |
| Q1 2018 | $467,827,000 | +1.2% | 7,129 | 0.0% | 0.18% | +2.2% |
| Q4 2017 | $462,262,000 | +281.4% | 7,129 | +210.9% | 0.18% | +262.0% |
| Q3 2017 | $121,192,000 | -72.6% | 2,293 | -68.6% | 0.05% | -73.3% |
| Q2 2017 | $442,310,000 | +34.9% | 7,304 | +15.3% | 0.19% | +29.0% |
| Q1 2017 | $327,974,000 | -1.5% | 6,334 | -15.5% | 0.14% | -4.0% |
| Q4 2016 | $332,813,000 | -6.8% | 7,499 | 0.0% | 0.15% | -8.5% |
| Q3 2016 | $356,952,000 | +7.7% | 7,499 | +2.1% | 0.16% | +7.8% |
| Q2 2016 | $331,508,000 | +16.3% | 7,344 | +5.8% | 0.15% | +13.3% |
| Q1 2016 | $285,000,000 | +26.1% | 6,944 | +13.5% | 0.14% | +17.4% |
| Q4 2015 | $226,000,000 | +15.3% | 6,119 | 0.0% | 0.12% | +10.6% |
| Q3 2015 | $196,000,000 | -19.0% | 6,119 | -3.9% | 0.10% | -13.3% |
| Q2 2015 | $242,000,000 | -39.2% | 6,369 | +8.5% | 0.12% | -39.4% |
| Q1 2015 | $398,000,000 | +221.0% | 5,869 | +247.5% | 0.20% | +230.0% |
| Q4 2014 | $124,000,000 | – | 1,689 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |